Your Partner.
Lina Hohmann
With a vision for building something meaningful, Lina is a founder that brings a blend of hands-on experience and big-picture thinking.
Managing Partner
Managing Partner
Mona Glogger
Dynamic, approachable, and driven by results, Mona is a founder that stands for building strong relationships and connect people to the right solutions.
We love what we do. Because AccessMatters to us.
Our Expertise
Background in Health Economics & Pharmaceutical Sciences
“Allrounder” providing hands-on end-to-end Market Access
Leadership industry expertise
Lina
Current: Managing Partner, AccessMatters
Key area of expertise: Pricing, (regional) Access, HTA, Immunology, Dermatology, Rheumatology, Neurology/Psychiatry, Fibrosis, Cardiovascular, Launch Expertise, sub-national rebate contracting, regional Access, claims data analysis
2024 - 2026: Lead Pricing x-Portfolio, BMS Germany
Responsibility for national pricing negotiations with GKV-SV according to §130b SGBV (AMNOG), sub-national innovative pricing agreements, proper financial planning within global pricing governance/budget/forecasting, monitoring/analyzing/evaluating pricing risks and opportunities for BMS Germany Portfolio […] People leader 5-10 employees.
2020 - 2024: Associate Director Market Access Immunology & Fibrosis, BMS Germany
Management of the early benefit assessment according to §35a SGB V AMNOG (incl. G-BA consultation, HTA dossier, written statement/oral hearing process), responsible for unrestricted prescription & reimbursement conditions, product pipeline assessment & early evidence strategy, access stakeholder management […] People leader 5-10 employees.
2020 - 2016: Manager Market Access Celgene/BMS
Pre 2016: J&J, HGC Healthcare Consulting, IQWiG […]
2014 - 2016: M.Sc. in Health Economics, Cologne/Germany
2011 – 2014: B.Sc. in Health Economics, Cologne/Germany
Mona
Current: Managing Partner, AccessMatters
Key area of expertise: Access, (EU-)HTA, Pricing, Hematology, Oncology , Launch Expertise, Orphan Drugs, ATMP (CAR-T), real world evidence obligation, Opt-Out
2025 - 2026: Owner and Founder, Glogger Consulting (MA & Pricing consultancy)
Access & Pricing consultation for biotech and pharmaceutical industry. Different consultation projects: hematology/ oncology, immunology, CV.
2021 - 2025: Associate Director Market Access Hematology, BMS Germany
Management of the early benefit assessment according to §35a SGB V AMNOG (incl. G-BA consultation, HTA dossier, written statement/oral hearing process), responsible for unrestricted prescription & reimbursement conditions, product pipeline assessment & early evidence strategy, access stakeholder management […] People leader 5-10 employees.